Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Shiv Ram Krishn, Israa Salem, Fabio Quaglia, Nicole M. Naranjo, Ekta Agarwal, Qin Liu, Srawasti Sarker, Jessica Kopenhaver, Peter A. McCue, Paul H. Weinreb, Shelia M. Violette, Dario C. Altieri & Lucia R. Languino. (2020) The αvβ6 integrin in cancer cell-derived small extracellular vesicles enhances angiogenesis. Journal of Extracellular Vesicles 9:1.
Read now
Read now
Vittore Cereda, Vincenzo Formica & Mario Roselli. (2018) Issues and promises of bevacizumab in prostate cancer treatment. Expert Opinion on Biological Therapy 18:6, pages 707-717.
Read now
Read now
Alexander C Small & William K Oh. (2012)
Bevacizumab treatment of prostate cancer. Expert Opinion on Biological Therapy 12:9, pages 1241-1249.
Read now
Read now
Articles from other publishers (26)
Camila M.L. Machado, Magdalena Skubal, Katja Haedicke, Fabio P. Silva, Evan P. Stater, Thais L.A. de O. Silva, Erico T. Costa, Cibele Masotti, Andreia H. Otake, Luciana N.S. Andrade, Mara de S. Junqueira, Hsiao-Ting Hsu, Sudeep Das, Benedict Mc Larney, Edwin C. Pratt, Yevgeniy Romin, Ning Fan, Katia Manova-Todorova, Martin Pomper & Jan Grimm. (2023) Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors. Journal of Controlled Release 364, pages 312-325.
Crossref
Crossref
Mostafa Abbaszadeh, Mehdi Dehghan & Dunhui Xiao. (2023) Investigation of phase-field models of tumor growth based on a reduced-order meshless Galerkin method. Engineering with Computers.
Crossref
Crossref
Niusha Narimani & Mehdi Dehghan. (2023) Predicting the effect of a combination drug therapy on the prostate tumor growth via an improvement of a direct radial basis function partition of unity technique for a diffuse-interface model. Computers in Biology and Medicine 157, pages 106708.
Crossref
Crossref
Pierluigi Colli, Hector Gomez, Guillermo Lorenzo, Gabriela Marinoschi, Alessandro Reali & Elisabetta Rocca. (2021) Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth. Mathematical Models and Methods in Applied Sciences 31:07, pages 1419-1468.
Crossref
Crossref
Pierluigi Colli, Hector Gomez, Guillermo Lorenzo, Gabriela Marinoschi, Alessandro Reali & Elisabetta Rocca. (2020) Mathematical analysis and simulation study of a phase-field model of prostate cancer growth with chemotherapy and antiangiogenic therapy effects. Mathematical Models and Methods in Applied Sciences 30:07, pages 1253-1295.
Crossref
Crossref
Jia Huang, Ziming Li, Zhengping Ding, Qingquan Luo & Shun Lu. (2015) Different roles of myofibroblasts in the tumorigenesis of nonsmall cell lung cancer. Tumor Biology 37:12, pages 15525-15534.
Crossref
Crossref
Tae-Dong Kim, Fang Jin, Sook Shin, Sangphil Oh, Stan A. Lightfoot, Joseph P. Grande, Aaron J. Johnson, Jan M. van Deursen, Jonathan D. Wren & Ralf Janknecht. (2016) Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1. Journal of Clinical Investigation 126:2, pages 706-720.
Crossref
Crossref
Sravani Pulya, Yadagiri Kommagalla, Duhita G. Sant, Shweta U. Jorwekar, Santosh G. Tupe, Mukund V. Deshpande & Chepuri V. Ramana. (2016) Re-engineering of PIP3-antagonist triazole PITENIN's chemical scaffold: development of novel antifungal leads. RSC Advances 6:14, pages 11691-11701.
Crossref
Crossref
Giovanna Mirone, Stefania Perna & Gabriella Marfe. 2016. Resistance to Tyrosine Kinase Inhibitors. Resistance to Tyrosine Kinase Inhibitors
27
107
.
SUSANNE GAHR, CHRISTIAN MAYR, TOBIAS KIESSLICH, ROMANA ILLIG, DANIEL NEUREITER, BEATE ALINGER, MARION GANSLMAYER, TILL WISSNIOWSKI, PIETRO DI FAZIO, ROBERTA MONTALBANO, JOACHIM H. FICKER, MATTHIAS OCKER & KARL QUINT. (2015) The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression. International Journal of Oncology 47:3, pages 963-970.
Crossref
Crossref
Qiruo Gao, Junhua Zheng, Xudong Yao & Bo Peng. (2015) Adiponectin inhibits VEGF-A in prostate cancer cells. Tumor Biology 36:6, pages 4287-4292.
Crossref
Crossref
Alessandra Fiorio Pla, Alessia Brossa, Michela Bernardini, Tullio Genova, Guillaume Grolez, Arnaud Villers, Xavier Leroy, Natalia Prevarskaya, Dimitra Gkika & Benedetta Bussolati. (2014) Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib. BMC Cancer 14:1.
Crossref
Crossref
Xinhai WanPaul G. CornJun YangNallasivam PalanisamyMichael W. StarbuckEleni EfstathiouElsa M. Li Ning TapiaAmado J. ZuritaAna AparicioMurali K. RavooriElba S. VazquezDan R. RobinsonYi-Mi WuXuhong CaoMatthew K. IyerWallace McKeehanVikas KundraFen WangPatricia TroncosoArul M. ChinnaiyanChristopher J. LogothetisNora M. Navone. (2014) Prostate cancer cell–stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. Science Translational Medicine 6:252.
Crossref
Crossref
Jason Boyang Wu, Chen Shao, Xiangyan Li, Qinlong Li, Peizhen Hu, Changhong Shi, Yang Li, Yi-Ting Chen, Fei Yin, Chun-Peng Liao, Bangyan L. Stiles, Haiyen E. Zhau, Jean C. Shih & Leland W.K. Chung. (2014) Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. Journal of Clinical Investigation 124:7, pages 2891-2908.
Crossref
Crossref
Ricarda Locher, Paola A. Erba, Burkhard Hirsch, Emilio Bombardieri, Leonardo Giovannoni, Dario Neri, Horst Dürkop & Hans D. Menssen. (2013) Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of 131I-L19SIP in a prostate cancer patient. Journal of Cancer Research and Clinical Oncology 140:1, pages 35-43.
Crossref
Crossref
Petros D. Grivas & David C. Smith. 2014. Management of Castration Resistant Prostate Cancer. Management of Castration Resistant Prostate Cancer
265
276
.
Daniel J. George, William Kelly & Aaron Mitchell. 2014. Management of Castration Resistant Prostate Cancer. Management of Castration Resistant Prostate Cancer
203
231
.
Neil R. Smith, Dawn Baker, Matthew Farren, Aurelien Pommier, Ruth Swann, Xin Wang, Sunita Mistry, Karen McDaid, Jane Kendrew, Chris Womack, Stephen R. Wedge & Simon T. Barry. (2013) Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy. Clinical Cancer Research 19:24, pages 6943-6956.
Crossref
Crossref
DONG HWAN KIM, MOHAMMAD AKBAR HOSSAIN, MIN YOUNG KIM, JIN-AH KIM, JEONG-HYUN YOON, HONG SUK SUH, GI-YOUNG KIM, YUNG HYUN CHOI, HAE YOUNG CHUNG & NAM DEUK KIM. (2013) A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells. International Journal of Oncology 43:6, pages 1915-1924.
Crossref
Crossref
Christopher J. Fowler, Andreas Josefsson, Lina Thors, Sui Chu Chung, Peter Hammarsten, Pernilla Wikström & Anders Bergh. (2013) Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1831:10, pages 1579-1587.
Crossref
Crossref
Deborah Mukherji, Sally Temraz, David Wehbe & Ali Shamseddine. (2013) Angiogenesis and anti-angiogenic therapy in prostate cancer. Critical Reviews in Oncology/Hematology 87:2, pages 122-131.
Crossref
Crossref
William L. Dahut, Ravi A. Madan, Joyson J. Karakunnel, David Adelberg, James L. Gulley, Ismail B. Turkbey, Cindy H. Chau, Shawn D. Spencer, Marcia Mulquin, John Wright, Howard L. Parnes, Seth M. Steinberg, Peter L. Choyke & William D. Figg. (2013)
Phase
II
clinical trial of cediranib in patients with metastatic castration‐resistant prostate cancer
. BJU International 111:8, pages 1269-1280.
Crossref
Crossref
Ugur Ozerdem, Eva M. Wojcik, Xiuzhen Duan, Çağatay Erşahin & Güliz A. Barkan. (2013) Prognostic utility of quantitative image analysis of microvascular density in prostate cancer. Pathology International 63:5, pages 277-282.
Crossref
Crossref
H. X. Yin, Z. H. Zhang, J. C. Shen, A. L. Zhang, T. Y. Zhang, J. X. Luo, C. Y. Fu, X. P. Yi, Z. W. Liu, S. S. Yang, B. Zhou & X. Fu. (2012) Scl gene construction, expression and effect on hemangioma. Molecular Biology Reports 40:4, pages 3381-3388.
Crossref
Crossref
Foroogh Nejatollahi, Soghra Abdi & Mahdi Asgharpour. (2013) Antiproliferative and Apoptotic Effects of a Specific Antiprostate Stem Cell Single Chain Antibody on Human Prostate Cancer Cells. Journal of Oncology 2013, pages 1-8.
Crossref
Crossref
Michael T. Schweizer & Michael A. Carducci. (2013) From Bevacizumab to Tasquinimod. The Cancer Journal 19:1, pages 99-106.
Crossref
Crossref